Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Standring

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Surgical Oncology|September 29, 2023
First-line Hepatic Artery Infusion for Unresectable CLM Works, but Will We Ever Get There?Oliver Standring, Sepideh Gholami
Surgery|June 15, 2023
Adjuvant hepatic artery infusion pump chemotherapy for resected colorectal cancer liver metastasesOliver Standring, Sepideh Gholami
Journal of Surgical Oncology|November 15, 2024
Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic CancerShruti Koti, Oliver Standring, Nandan Vithlani, et al.
American Journal of Surgery|October 5, 2023
Decreasing utilization of surgical interventions amongst patients with pancreatic neuroendocrine tumor with liver metastasesNeda Amini, Lyudmyla Demyan, Manav Shah, et al.
Journal of Surgical Oncology|November 11, 2024
Evaluating the Association of Area Deprivation Index (ADI) on Postoperative Outcomes in Pancreatic AdenocarcinomaAbdullah Khalid, Shamsher A Pasha, Lyudmyla Demyan, et al.
Langenbeck'S Archives of Surgery|September 21, 2024
Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic CancerAbdullah Khalid, Shamsher A Pasha, Lyudmyla Demyan, et al.
Annals of Surgical Oncology|July 27, 2021
Ampullary Neuroendocrine Tumors: Insight into a Rare HistologySamantha M Ruff, Oliver Standring, Grace Wu, et al.
Annals of Surgical Oncology|June 7, 2024
ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer CareJohn Fallon, Oliver Standring, Nandan Vithlani, et al.
Annals of Surgical Oncology|May 24, 2024
Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis SettingJohn Fallon, Oliver Standring, Nandan Vithlani, et al.
Annals of Surgical Oncology|May 26, 2023
Potential Role for Observation in Small Solid Pseudopapillary Neoplasm (SPN)Oliver Standring, Susana Benitez Sanchez, Shamsher Pasha, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Surgical Oncology|September 29, 2023
First-line Hepatic Artery Infusion for Unresectable CLM Works, but Will We Ever Get There?Oliver Standring, Sepideh Gholami
Surgery|June 15, 2023
Adjuvant hepatic artery infusion pump chemotherapy for resected colorectal cancer liver metastasesOliver Standring, Sepideh Gholami
Journal of Surgical Oncology|November 15, 2024
Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic CancerShruti Koti, Oliver Standring, Nandan Vithlani, et al.
American Journal of Surgery|October 5, 2023
Decreasing utilization of surgical interventions amongst patients with pancreatic neuroendocrine tumor with liver metastasesNeda Amini, Lyudmyla Demyan, Manav Shah, et al.
Journal of Surgical Oncology|November 11, 2024
Evaluating the Association of Area Deprivation Index (ADI) on Postoperative Outcomes in Pancreatic AdenocarcinomaAbdullah Khalid, Shamsher A Pasha, Lyudmyla Demyan, et al.
Langenbeck'S Archives of Surgery|September 21, 2024
Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic CancerAbdullah Khalid, Shamsher A Pasha, Lyudmyla Demyan, et al.
Annals of Surgical Oncology|July 27, 2021
Ampullary Neuroendocrine Tumors: Insight into a Rare HistologySamantha M Ruff, Oliver Standring, Grace Wu, et al.
Annals of Surgical Oncology|June 7, 2024
ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer CareJohn Fallon, Oliver Standring, Nandan Vithlani, et al.
Annals of Surgical Oncology|May 24, 2024
Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis SettingJohn Fallon, Oliver Standring, Nandan Vithlani, et al.
Annals of Surgical Oncology|May 26, 2023
Potential Role for Observation in Small Solid Pseudopapillary Neoplasm (SPN)Oliver Standring, Susana Benitez Sanchez, Shamsher Pasha, et al.
Pageof 1